Comparison of Conventional ELISA with Electrochemiluminescence Technology for Detection of Amyloid-β in Plasma-Reference-Cited by-同舟云学术

Comparison of Conventional ELISA with Electrochemiluminescence Technology for Detection of Amyloid-β in Plasma

Published:2010-09-02 Issue:3 Volume:21 Page:769-773
ISSN:1875-8908
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Oh Esther S.¹²³,Mielke Michelle M.²,Rosenberg Paul B.²,Jain Alka¹,Fedarko Neal S.¹,Lyketsos Constantine G.²,Mehta Pankaj D.⁴

Affiliation:

1. Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

2. Department of Psychiatry, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

3. Department of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA

4. Institute for Basic Research in Developmental Disabilities, Department of Developmental Neurobiology, Division of Immunology, Staten Island, NY, USA

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relevance of plasma biomarkers to pathologies in Alzheimer’s disease, Parkinson’s disease and frontotemporal dementia;Scientific Reports;2022-10-26

2. Aptamer-Functionalized Carbon Nanotube Field-Effect Transistor Biosensors for Alzheimer’s Disease Serum Biomarker Detection;ACS Sensors;2022-07-11

3. Evidence of plasma biomarkers indicating high risk of dementia in cognitively normal subjects;Scientific Reports;2022-01-24

4. Progress of Nanotechnology-Based Detection and Treatment of Alzheimer’s Disease Biomarkers;Nanoscale Engineering of Biomaterials: Properties and Applications;2022

5. Proteomic and metabolomic biomarkers of Alzheimer's disease: Opportunities to advance precision medicine and clinical trials;The Neurobiology of Aging and Alzheimer Disease in Down Syndrome;2022